Management of spermatic cord tumors: a rare urologic malignancy
Rodríguez, D., and A. F. Olumi. 2012. Management of Spermatic Cord Tumors: A Rare Urologic Malignancy.
Search
Search results
112 results found
Personalized medicine for the management of benign prostatic hyperplasia
Bechis, S. K., A. G. Otsetov, R. Ge, and A. F. Olumi. 2014. Personalized Medicine for the Management of Benign Prostatic Hyperplasia.
Prognostic significance of indeterminate lung nodules in renal cell carcinoma
Xu, R., N. Horick, F. J. McGovern, D. M. Dahl, A. S. Feldman, M. L. Blute, A. F. Olumi, and M. D. Michaelson. 2014. Prognostic Significance of Indeterminate Lung Nodules in Renal Cell Carcinoma.
Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia
Bechis, S. K., A. G. Otsetov, R. Ge, Z. Wang, M. G. Vangel, C. L. Wu, S. Tabatabaei, and A. F. Olumi. 2015. Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia.
Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma
Cornejo, K. M., M. Lu, P. Yang, S. Wu, C. Cai, W. D. Zhong, A. Olumi, R. H. Young, and C. L. Wu. 2015. Succinate Dehydrogenase B: A New Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53
Liu, Q., L. Gheorghiu, M. Drumm, R. Clayman, A. Eidelman, M. F. Wszolek, A. Olumi, et al. 2018. PARP-1 Inhibition With or Without Ionizing Radiation Confers Reactive Oxygen Species-Mediated Cytotoxicity Preferentially to Cancer Cells With Mutant TP53.
Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome
Wu, S., S. X. Lin, G. J. Wirth, M. Lu, J. Lu, A. O. Subtelny, Z. Wang, D. M. Dahl, A. F. Olumi, and C. L. Wu. 2019. Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome.
Advancing bladder preservation: Biomarkers, decision-making, and therapy
McConkey, D., C. J. M. Best, J. A. Gumminger, and A. F. Olumi. 2021. Advancing Bladder Preservation: Biomarkers, Decision-Making, and Therapy.
The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillance
Monfared, S., A. Fleishman, R. Korets, P. Chang, A. Wagner, G. Bubley, I. Kaplan, A. F. Olumi, and B. Gershman. 2021. The Impact of Pretreatment PSA on Risk Stratification in Men With Gleason 6 Prostate Cancer: Implications for Active Surveillance.
Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder
Bharadwaj, M., S. Kaul, A. Fleishman, R. Korets, P. Chang, A. Wagner, S. Kim, et al. 2022. Adjuvant Chemotherapy versus Observation Following Radical Cystectomy for Locally Advanced Urothelial Carcinoma of the Bladder.